Aurora Cannabis’ (ACB) price analysis shows weak future
Aurora Cannabis (ACB) currently trades at $0.67 and has fallen by 5.12% today. ACB went down $0.03 from the previous closing price of $0.71. The high forecast for Aurora Cannabis is $3.00 and the low is $0.30. The company’s market cap is $883.85 million with a 52 week high of $9.37 and a 52 week low of $0.60. ACB has changed in price by -8.17 per share in the last 12 months. Aurora Cannabis announced a 12-to-1 reverse stock split and issued arguably soft revenue guidance for Q3, these developments do not paint an encouraging picture for Aurora’s investors.
Aurora Cannabis has a strong EPS of 0.21. This means the company made $0.21 per share after paying dividends, this can indicate that the stock is a safe investment. EPS is calculated as a company’s profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company’s profitability. It is common for a company to report EPS that is adjusted for extraordinary items and potential share dilution. Based on this information, investorsQ rates this stock 4 out of 10. We give it this rating based on current information written in this article.
About Aurora Cannabis:
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.